Researchers have identified a key enzyme driving forms of Parkinson's disease, and have shown how blocking it restores normal ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

ZyVersa CEO Stephen Glover said, “ZyVersa is developing Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases, with ...

Invited MJFF grant request for funding of a second IC 100 proof-of-concept preclinical study in Parkinson’s disease animal model has been submitted; response expected in June 2025. We look ...

In the early 2000s, a revolution began in Parkinson’s Disease. Animal studies showed for the ... as frontline medicine for PD. A unique model, PWR! integrates PD-specific rehabilitation and ...

Florida Atlantic University received a $2 million philanthropic donation on March 10 from Philanthropist David Nicholson, which the university is planning to use to launch a center called the “David ...

Researchers have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the ...